Browse > Article
http://dx.doi.org/10.4333/KPS.2007.37.2.119

Analysis of Prescriptions for Oral Solid Dosage Forms Split at Primary Health Care Using National Health Insurance Database  

Park, Se-Jung (Medtronic Korea)
Lee, Suk-Hyang (Sookmyung Women's University Graduate School of Clinical Pharmacy)
Lee, Eui-Kyung (Sookmyung Women's University Graduate School of Clinical Pharmacy)
Publication Information
Journal of Pharmaceutical Investigation / v.37, no.2, 2007 , pp. 119-126 More about this Journal
Abstract
Tablet splitting is used in pharmacy practice to adjust the dose to be administered. However, it also causes several problems such as undesirable effect for sustained release or enteric-coated dosage form, inaccuracy of dose, and pharmacist's safety by splitting hazardous drugs. This study investigated the current status of oral dosage form splitting for patients older than 19 years by analyzing Korea National Health Insurance Claims Database. Out of oral solid drugs prescribed (N=1,486,584) 9.8% of them included tablets (or capsules) split. There were some splitting cases even in sustained release (4.9%), enteric-coated forms (1.3%) and hazardous drugs (2.7%) that were selected by NIOSH (The National Institute for Occupational Safety and Health). The most frequently split drugs were antihistamines, neuropsychotics and steroids. In case of digoxin and warfarin, unit doses in a domestic market were not diverse compared to foreign markets. Guidelines for splitting oral solid dosage forms, approval of diverse doses and conducting dose-response studies for the commonly splitting ingredients on Korean people are needed for the saff and effective use of oral solid drugs.
Keywords
Tablet splitting; Capsule splitting; Oral dosage form; Enteric-coated form;
Citations & Related Records
연도 인용수 순위
  • Reference
1 J. E. Polli, S. Kim and B. R. Martin, Weight uniformity of split tablets required by a Veterans Affairs policy, Manag. Care Pharm., 5, 401-407 (2003)
2 P. J. Vuchetich, R. I. Garis and, A. M. Jorgensen, Evaluation of cost savings to a state Medicaid program following a sertraline tablet-splitting program, J. Am. Pharm. Assoc. (Wash DC), 4, 497-502 (2003)
3 http://www.bayeraspirin.co.kr/
4 http://www.drugs.com/MMX/Omeprazole.html
5 J. M. Rosenberg, J. P. Nathan, and F. Plakogiannis, Weight variability of pharmacist-dispensed split tablets, J Am Pharm Assoc (Wash), 2, 200-205 (2002)
6 J. Teng, C. K. Song, R. L. Williams and J. E. Polli, Lack of medication dose uniformity in commonly split tablets, J Am Pharm Assoc. (Wash), 2, 195-199 (2002)
7 T. J. Cook, S. Edwards, C. Gyemah, M. Shah, I. Shah and T. Fox, Variability in tablet fragment weights when splitting unscored cyclobenzaprine 10 mg tablets., J. Am. Pharm. Assoc. (Wash DC), 5, 583-586 (2004)
8 J. T. McDevitt, A. H. Gurst and Y. Chen, Accuracy of tablet splitting, Pharmacotherapy, 1, 193-1,197 (1998)
9 R. S. Stafford and D. C. Radley, The potential of pill splitting to achieve cost savings, Am. J. Manag. Care, 8, 706-712 (2002)
10 M. S. Fischbach, J. L. Gold, M. Lee, J. M. Dergal, G. M. Litner and R. A. Rochon, Pill-splitting in a long-term care facility, Can. Med. Assoc. J., 164, 785 - 786 (2001)
11 C. I. Cohen and S. I. Cohen, Potential savings from splitting newer antidepressant medications, CNS Drugs, 16, 353-358 (2002)   DOI   ScienceOn
12 American Society of Hospital Pharmacists, ASHP technical assistance bulletin on handling cytotoxic and hazardous drugs, Am. J. Hasp. Pharm., 47, 1033-1049 (1990)
13 http://www.cdc.gov/niosh/docs/2004-165/#sum
14 BitDruginfo 홈페이지 http://www.druginfo.co.kr
15 http://www.osha.gov/dts/osta/otm/otm_vi/otm _vi_2.html
16 식약청 홈페이지 http://ezdrug.kfda.go.kr/
17 미국 식약청 홈페이지 http://www.fda.gov/cder/ob/docs/queryai.htm
18 킴스온라인 홈페이지 http://www.kimsonline.co.kr/